100
Participants
Start Date
May 9, 2024
Primary Completion Date
September 30, 2026
Study Completion Date
April 30, 2027
Subtreshold micropulse laser therapy
Laser-treated group will receive additional subthreshold micropulse laser therapy (SMLT) 1 month after pars plana vitrectomy (PPV), using a 577 nm solid-state yellow diode laser applied to the macular area (thirty 5 × 5 spot sizes of 160 µm, zero-spot spacing, including the fovea; fixed power 250 mW; exposure time 200 ms; micropulse mode, 5% duty cycle). Control group (nonlaser group) will not receive additional laser treatment.
Pars plana vitrectomy
Both groups will undergo pars plana vitrectomy (PPV) with epiretinal membrane (ERM) and internal limiting membrane (ILM) peeling prior to allocation to study arms.
First Department of Ophthalmology, Pomeranian Medical University, Szczecin
Pomeranian Medical University Szczecin
OTHER